Interim clinical results from Project IMPACT: Diabetes, announced today by the American Pharmacists Association (APhA) Foundation, show statistically significant decreases in A1C or blood sugar levels, LDL cholesterol, systolic blood pressure and Body Mass Index (BMI), which are all recognized standards of diabetes care. Participating patients in 25 communities who experienced improved outcomes encompass almost every socioeconomic class, insurance status and ethnicity.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62268-american-pharmacists-association-apha-foundation-project-impact-diabetes
Do you know how to recognize a stroke? Would you know what to do if someone — or you — had one? Many people don't, and 795,000 people in the United States will have a stroke this year.
In a recent American Heart Association/American Stroke Association survey, only 41 percent of people who care for family with significant risk factors for a first-time stroke could name at least three stroke warning signs.
As part of World Stroke Day on Oct. 29, and National Family Caregivers Month in November, the American Stroke Association is urging Americans to learn the stroke warning signs and to act fast when a stroke occurs.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62321-world-stroke-day-survey-prepare-for-stroke-emergency
Cochlear Limited, the global leader in implantable hearing solutions, has announced the launch of Nucleus® 6 in India, its next generation cochlear implant sound processor.
Nucleus 6 delivers industry first innovations designed to provide superior outcomes in a way that makes hearing a lot easier for the recipient – in the smallest sound processor on the market.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/63489-cochlear-announces-nucleus-6-system
November is National Alzheimer’s Disease Awareness Month, a time to focus on finding ways to prevent the disease and enrich the lives of millions of Americans who live with, or care for, someone with Alzheimer’s. Brookdale, a leading owner and operator of senior living solutions throughout the United States, has a long-standing commitment to support research to reduce the impact of Alzheimer’s, which is the sixth leading cause of death in the United States.
To view Multimedia News Release, go to http://www.multivu.com/players/English/64011-brookdale-senior-living-alzheimer-awareness/
According to a new AARP poll1, almost three out of ten people who are caring for a loved one say their life has changed since becoming a caregiver. More than one in five says their weight, exercise, or social life has suffered.
To illustrate the complexity and help the 42 million sons and daughters, friends and spouses caring for parents and loved ones see themselves as caregivers, AARP and the Ad Council are unveiling a new suite of Public Service Advertisements (PSAs) as part of their Caregiver Assistance campaign. The PSAs will be distributed today as part of National Family Caregivers Month (November) and direct caregivers to tools and resources to help cope with their daily responsibilities at aarp.org/caregiving.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/63968-ad-council-aarp-caregiver-assistance
Diabetic Foot Ulcers (DFUs) are one of the most common, yet treatable, complications in people with diabetes. As part of World Diabetes Day, Shire is today urging diabetes patients to have their feet checked and visit www.healtogether.com to better understand the complications associated with diabetes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64401-shire-urges-people-with-diabetes-feet-for-wounds-world-diabetes-day
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Merck for Mothers has launched programs aimed at decreasing the number of women across the United States who die from or suffer severe complications related to pregnancy and childbirth.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62776-merck-for-mothers-working-to-reduce-maternal-mortality-rate
Phiten, the pioneer of AQUA-METAL™ materials and innovator of metal-infused technology, and professional baseball players C.J. Wilson, Josh Hamilton and J.B. Shuck have teamed up with Be The Match, the nonprofit organization dedicated to helping patients with blood cancers receive life-saving bone marrow and umbilical cord blood transplants. To support Be The Match and raise awareness of the national Be The Match Registry®, Phiten has designed a limited edition Phiten x Be The Match Tornado Necklace with sales benefiting the cause, and the three pro baseball players have been named Ambassadors of Hope by Be The Match.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64376-phiten-and-mlb-players-for-be-the-match-bone-marrow-donor-registry
Philips Respironics, a unit of Royal Philips (NYSE: PHG, AEX: PHIA) and a pioneer in science-based sleep solutions, brings a new comfort option to its best-selling, most comfortable full face mask that fits most patients. The Amara gel cushion option is part of a groundbreaking series of new masks and services that are setting a new standard for patient care.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64501-philips-respironics-amara-gel-cushion-face-mask-sleep-apnea
Results from the global Diabetes Attitudes, Wishes and Needs 2 study (DAWN2™) presented today at a symposium during the World Diabetes Congress of the International Diabetes Federation (IDF), show that only 29% of people with diabetes report that their healthcare team ask for their input when making their treatment plans. Furthermore, only 33% said they were encouraged by their healthcare professional to ask questions in the consultation.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64152-novo-nordisk-diabetes-report-doctor-treatment
In recent years there has been a shift in the understanding of cancer. Immunotherapy with vaccines has been emerging as the most promising direction towards a decisive improvement of treatment outcomes.
The Dendritic Cell Vaccine has received FDA approval for prostate cancer and trials are now under way for a variety of other cancers. These vaccines are usually administered on their own.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64654-issels-integrative-immunotherapy-for-standard-therapy-resistant-cancers
The first comprehensive long-term study comparing different medications for type 2 diabetes is launching nationwide. The GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness) Study will compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64578-grade-glycemia-reduction-approaches-in-diabetes-comparative-effectiveness
